A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma. - Weiner AK; Radaoui AB; Tsang M; Martinez D; Sidoli S; Conkrite KL; Delaidelli A; Modi A; Rokita JL; Patel K; Lane MV; Zhang B; et al. (BioRxiv : the preprint server for biology, 2024)